Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kelly Silvestri"'
Autor:
Shannon Puhalla, Michelle E. Melisko, Kimberly L. Blackwell, Polly A. Niravath, Karen L. Smith, Antonio C. Wolff, Kathryn P. Componeschi, Kelly Silvestri, Nadine Tung, Rachel C. Jankowitz, Timothy J. Moynihan, Roisin M. Connolly, Paula R. Pohlmann, Juan M. Marte, Heather A. Parsons, Anne Cropp, Robyn Burns, Nuhad K. Ibrahim, Christine M Cotter, Julie R. Nangia, Rachel A. Freedman, Beverly Moy, Rebecca Gelman, Nan Lin, Mothaffar F. Rimawi, Ian E. Krop, Carey K. Anders, Eric P. Winer, Catherine Van Poznak, Ciara C. O’Sullivan
Publikováno v:
Journal of Clinical Oncology
PURPOSE Evidence-based treatments for metastatic, human epidermal growth factor receptor 2 (HER2)–positive breast cancer to the CNS are limited. We previously reported modest activity of neratinib monotherapy for HER2-positive breast cancer brain m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::980d614c743ac2880714d633b0033347
https://pubmed.ncbi.nlm.nih.gov/30940923
https://pubmed.ncbi.nlm.nih.gov/30940923
Autor:
Rachel A. Freedman, Ian E. Krop, Kelly Silvestri, Juan M. Marte, Roisin M. Connolly, Michelle E. Melisko, Robyn Burns, Ian F. Dunn, Beverly Moy, Carey K. Anders, Shannon Puhalla, Nuhad K. Ibrahim, Sandro Santagata, Nathalie Y. R. Agar, Julie R. Nangia, Timothy J. Moynihan, Elizabeth C. Randall, Catherine Van Poznak, Begoña Gimenez-Cassina Lopez, Rebecca Gelman, Kimberly L. Blackwell, Nan Lin, Mothaffar F. Rimawi, Nadine Tung, Christine M Cotter, Antonio C. Wolff, Eric P. Winer, Kathryn P. Componeschi
Publikováno v:
Clinical Breast Cancer. 20:145-151.e2
Purpose This pilot study was performed to test our ability to administer neratinib monotherapy before clinically recommended craniotomy in patients with HER2-positive metastatic breast cancer to the central nervous system, to examine neratinib’s ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad32b9ec81cec0c06d4e3979b792ea1f
https://doi.org/10.1016/j.clbc.2019.07.011
https://doi.org/10.1016/j.clbc.2019.07.011
Autor:
Ian E. Krop, Hao Guo, Sara M. Tolaney, Priya Kumthekar, Romualdo Barroso-Sousa, Kelly Silvestri, Eric P. Winer, Nan Lin, William T. Barry
Publikováno v:
Journal of Clinical Oncology. 36:TPS1100-TPS1100
TPS1100Background: There is no clear standard of care to address the management of refractory CNS metastases in HER2+ MBC. The ongoing study (NCT03417544) is evaluating the efficacy of the combinat...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa4b62797e054f9f8f5e564f99ff95a8
https://doi.org/10.1200/jco.2018.36.15_suppl.tps1100
https://doi.org/10.1200/jco.2018.36.15_suppl.tps1100